Connect with us

MAM

Eris Lifesciences strengthens pulse with Murari Ranganathan’s appointment

Published

on

MUMBAI: Eris Lifesciences is set to beat stronger in the cardiometabolic space with the appointment of Murari Ranganathan as president, cardiometabolic business. Stepping into the Mumbai office, he will spearhead the company’s Anti-Diabetes and Cardiology divisions, two of Eris’ flagship verticals.

Eris Lifesciences chairman and managing director Amit Bakshi said, “Murari’s expertise will be invaluable in strengthening our position in the cardiometabolic segment. We’re thrilled to have him on board and look forward to the milestones ahead.”

On his appointment, Ranganathan said, “Eris Lifesciences is the youngest player among the top 20 pharmaceutical companies in India, and its dynamic, entrepreneurial culture is truly inspiring. I look forward to working with the team to set new benchmarks in disease management and patient care.”

Advertisement

Ranganathan brings over two decades of industry experience, having previously served as commercial director at Abbott India Ltd, where he led women’s health, metabolics, and international business. His career spans leadership roles at Baxter, Novo Nordisk, and Torrent Pharma, and he holds a Postgraduate Diploma in Marketing from St. Joseph College of Business Administration, Bangalore.

With this strategic move, Eris Lifesciences is set to fortify its presence in one of India’s fastest-growing healthcare segments, keeping its commitment to innovation and patient well-being at the heart of its expansion.

Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

MAM

Dish TV shareholders approve three independent directors

99.49 per cent vote of confidence strengthens board as company expands into connected TV, e-commerce and OTT.

Published

on

MUMBAI: Dish TV has just been served a near-perfect vote of confidence and the shareholders have dished it out in style. Shareholders of the DTH operator have approved the appointment of three new Independent Directors with an overwhelming 99.49 per cent approval. The three appointees are Mr Arun Kumar Kapoor, Ms Heena Naishadh Bhatt and Mr Ashok Anant Paranjpe.

The strong mandate reflects continued investor faith in the company’s strategy, disciplined execution and long-term value creation. It comes as Dish TV focuses on stabilising its core DTH business while actively scaling new verticals connected TV platform VZY, B2B e-commerce ShopZop, and OTT service Watcho to build a more diversified and resilient growth trajectory.

Dish TV India Limited, CEO & executive director Manoj Dhobhal said, “We are encouraged by the shareholders’ approval of the appointment of the Independent Directors and sincerely thank them for their continued trust and confidence. The Board is already benefiting from the Directors’ collective experience, which will further sharpen strategic focus and support disciplined execution.”

Advertisement

With a fresh, strengthened board in place, Dish TV is well positioned to navigate the evolving media landscape. In a sector where every percentage point matters, a 99.49 per cent thumbs-up is the kind of ringing endorsement that suggests the company’s recipe for the future is already tasting right.

Advertisement
Continue Reading

Advertisement News18
Advertisement
Advertisement
Advertisement
Advertisement Whtasapp
Advertisement Year Enders

Indian Television Dot Com Pvt Ltd

Signup for news and special offers!

Copyright © 2026 Indian Television Dot Com PVT LTD